Switzerland Biotechnology & Medical Research

Basilea Pharmaceutica AG (BSLN)

Track

Over the past 90 days, Basilea Pharmaceutica AG has seen exclusively sell-side activity from insiders, totaling approximately 101,559 CHF in net value. These transactions occurred following the company's February 2026 results financiers. The stock has experienced a 4.7% decline over the last quarter, currently trading near the midpoint of its 52-week range.
Ticker: BSLN Exchange: SWX
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Basilea Pharmaceutica AG. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Sale 29 May 2026
Value CHF4,843,904.34 | Price 329.70 | Shares 46,674
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-29 2026-05-29 S Sale Executive Director / Officer
46,674
329.70
CHF4,843,904 		46,674 329.70 CHF4,843,904
2026-05-13 2026-05-13 S Sale Executive Director / Officer
1,466
446.26
CHF3,083,877 		1,466 446.26 CHF3,083,877
2026-04-30 2026-04-30 S Sale Executive Director / Officer
57,490
405.78
CHF2,847,001 		57,490 405.78 CHF2,847,001
2026-04-20 2026-04-20 S Sale Executive Director / Officer
1,000
56.40
CHF56,400 		1,000 56.40 CHF56,400
2026-04-17 2026-04-17 S Sale Executive Director / Officer
1,000
56.00
CHF56,000 		1,000 56.00 CHF56,000
2026-04-15 2026-04-15 S Sale Executive Director / Officer
1,500
10.40
CHF15,600 		1,500 10.40 CHF15,600
2026-02-26 2026-02-26 S Sale Executive Director / Officer
2,000
9.40
CHF18,800 		2,000 9.40 CHF18,800
2026-02-24 2026-02-24 S Sale Executive Director / Officer
1,500
7.20
CHF10,800 		1,500 7.20 CHF10,800
2026-02-20 2026-02-20 S Sale Executive Director / Officer
600
54.68
CHF32,807 		600 54.68 CHF32,807
2025-11-24 2025-11-24 S Sale Executive Director / Officer
600
48.20
CHF28,920 		600 48.20 CHF28,920
2025-09-30 2025-09-30 S Sale Executive Director / Officer
1,200
47.00
CHF56,400 		1,200 47.00 CHF56,400
2025-05-21 2025-05-21 S Sale Executive Director / Officer
600
45.00
CHF27,000 		600 45.00 CHF27,000
2025-04-30 2025-04-30 S Sale Executive Director / Officer
400
44.00
CHF17,600 		400 44.00 CHF17,600
2025-04-23 2025-04-23 S Sale Executive Director / Officer
1,369
41.93
CHF57,396 		1,369 41.93 CHF57,396
2025-04-23 2025-04-23 S Sale Non-Executive Director
730
41.55
CHF30,331 		730 41.55 CHF30,331
2025-04-17 2025-04-17 S Sale Executive Director / Officer
1,000
41.26
CHF41,256 		1,000 41.26 CHF41,256
2025-04-17 2025-04-17 S Sale Executive Director / Officer
2,874
41.26
CHF118,569 		2,874 41.26 CHF118,569
2025-04-17 2025-04-17 S Sale Executive Director / Officer
4,205
41.26
CHF173,480 		4,205 41.26 CHF173,480
2024-10-28 2024-10-28 S Sale Executive Director / Officer
500
45.00
CHF22,500 		500 45.00 CHF22,500
2024-04-25 2024-04-25 S Sale Executive Director / Officer
1,950
41.01
CHF79,966 		1,950 41.01 CHF79,966
Explore more

More insider trading research around Basilea Pharmaceutica AG

More insider trades in Switzerland
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in Europe
Insider trades in Swiss Performance Index